by Team Small News | Jan 10, 2026 | Aurobindo Pharma, Pharma
A federal judge in Connecticut has rejected a request by Mylan Pharmaceuticals and Aurobindo Pharma USA to dismiss antitrust litigation against them. The judge ruled that a coalition of states has presented sufficient evidence to raise a genuine dispute about whether...
by Team Small News | Jan 10, 2026 | Divi's Laboratories
Jefferies, a global investment bank, has released its latest report on the Contract Research and Development Manufacturing Organization (CRDMO) sector. The report highlights top picks and revises target prices for several key players in the industry. Sai Life Sciences...
by Team Small News | Jan 8, 2026 | Divi's Laboratories
The Indian pharmaceutical sector is offering investors a chance to build a strong portfolio under the theme “Ayush Kart”, as stated by Siddharth Sedani, Managing Director at Anand Rathi. The Indian pharma sector has been growing rapidly, and this trend is... by Team Small News | Jan 7, 2026 | Biocon, Pharma
Biocon Biologics Ltd (BBL), a subsidiary of Biocon Limited, has announced plans to expand its oncology portfolio with the introduction of three new biosimilar candidates. The new additions include biosimilar versions of Trastuzumab/Hyaluronidase, Nivolumab, and...
by Team Small News | Jan 7, 2026 | Dr Reddy's
Dr. Reddy’s Laboratories has launched Hevaxin, a novel recombinant vaccine for the prevention of Hepatitis E virus (HEV) infection in India. This vaccine is the only one approved by the Drug Controller General of India (DCGI) for active immunization against HEV...